Eden Research (LON:EDEN) Stock Price Down 3.3% – What’s Next?

Shares of Eden Research plc (LON:EDEN) traded down 3.3% during mid-day trading on Friday . The company traded as low as GBX 3.30 ($0.04) and last traded at GBX 3.48 ($0.04). 450,985 shares changed hands during mid-day trading, a decline of 52% from the average session volume of 933,021 shares. The stock had previously closed at GBX 3.60 ($0.05).

Eden Research Price Performance

The business’s 50-day simple moving average is GBX 3.87 and its 200-day simple moving average is GBX 3.95. The stock has a market cap of £18.56 million, a PE ratio of -12.19 and a beta of 0.92. The company has a quick ratio of 2.42, a current ratio of 3.80 and a debt-to-equity ratio of 1.26.

Insider Buying and Selling at Eden Research

In related news, insider Alexander John Abrey bought 540,540 shares of the business’s stock in a transaction dated Tuesday, January 28th. The shares were purchased at an average price of GBX 4 ($0.05) per share, with a total value of £21,621.60 ($27,317.25). Also, insider Lykele van der Broek bought 256,000 shares of the business’s stock in a transaction dated Thursday, February 6th. The shares were bought at an average cost of GBX 4 ($0.05) per share, for a total transaction of £10,240 ($12,937.46). Corporate insiders own 14.02% of the company’s stock.

Eden Research Company Profile

Eden Research is the only UK-listed company focused on biopesticides for sustainable agriculture. It develops and supplies innovative biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries.

Eden’s products are formulated with terpene active ingredients, based on natural plant defence metabolites.